Aethlon Medical, Inc. (AEMD)
USD 0.35
(0.83%)
USD 0.35
(0.83%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -10.12 Million | -10.5 Million | -9.76 Million | -6.76 Million | -5.19 Million | -4.29 Million |
| Net Income | -12.2 Million | -12.02 Million | -10.42 Million | -7.89 Million | -6.38 Million | -6.21 Million |
| Depreciation & Amortization | 359.05 Thousand | 240.89 Thousand | 123.68 Thousand | 39.93 Thousand | 26.36 Thousand | 30.69 Thousand |
| Deferred income taxes | - | 46.76 Million | - | - | 395.82 Thousand | - |
| Stock-based compensation | 1.21 Million | 1.05 Million | 750.62 Thousand | 779.42 Thousand | 843.99 Thousand | 1.31 Million |
| Change in working capital | 478.65 Thousand | 65.33 Thousand | -251.11 Thousand | 309.69 Thousand | -115 Thousand | 435.87 Thousand |
| Other non-cash items | 1.8 Million | -46.59 Million | 30.53 Thousand | -2491.00 | 31.25 Thousand | 140.49 Thousand |
| Investing Cash Flow | -250.86 Thousand | -943.1 Thousand | -349.19 Thousand | -59.88 Thousand | -151.66 Thousand | - |
| Investments in PPE | -250.86 Thousand | -943.1 Thousand | -349.19 Thousand | -59.88 Thousand | -151.66 Thousand | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | -349 Thousand | -60 Thousand | -152 Thousand | - |
| Financing Cash Flow | 1.28 Million | 8.91 Million | 17.36 Million | 7.12 Million | 11.12 Million | 1.14 Million |
| Debt repayment | - | - | - | - | -992.59 Thousand | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | -12.49 Thousand | -88.11 Thousand | -132.52 Thousand | -40.93 Thousand | -193.86 Thousand |
| Common Stock Issuance | 1.32 Million | 8.92 Million | 17.45 Million | 7.26 Million | 12.15 Million | 1.34 Million |
| Other Financing Activities | -34.77 Thousand | 8.92 Million | -88.11 Thousand | -132.52 Thousand | 40.93 Thousand | 1.34 Million |
| Accounts receivables | - | 127.96 Thousand | 21.11 Thousand | 57.64 Thousand | -206.72 Thousand | 74.81 Thousand |
| Accounts payables | 156.67 Thousand | -174.72 Thousand | 97.54 Thousand | 341.85 Thousand | -16.76 Thousand | 390.34 Thousand |
| Inventory | - | 456.64 Thousand | - | -104.66 Thousand | 8491.00 | -74.81 Thousand |
| Other working capital | 321.98 Thousand | -344.54 Thousand | -369.76 Thousand | 14.84 Thousand | 100 Thousand | 45.53 Thousand |
| Cash at beginning of period | 14.53 Million | 17.15 Million | 9.9 Million | 9.6 Million | 3.82 Million | 6.97 Million |
| Cash at end of period | 5.44 Million | 14.62 Million | 17.15 Million | 9.9 Million | 9.6 Million | 3.82 Million |
| Capital Expenditure | -250.86 Thousand | -943.1 Thousand | -349.19 Thousand | -59.88 Thousand | -151.66 Thousand | - |
| Effect of forex changes on cash | 2107.00 | -5.95 Million | - | - | - | - |
| Net cash flow / Change in cash | -9.09 Million | -2.53 Million | 7.25 Million | 303.52 Thousand | 5.77 Million | -3.14 Million |
| Free Cash Flow | -10.38 Million | -11.44 Million | -10.11 Million | -6.82 Million | -5.34 Million | -4.29 Million |
| Breakdown | 2024 FY | 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -12.2 Million | -2.42 Million | -3.46 Million | -3.03 Million | -3.28 Million | -12.02 Million |
| Depreciation & Amortization | 359.05 Thousand | 85.83 Thousand | 90.9 Thousand | 91.42 Thousand | 90.32 Thousand | 240.89 Thousand |
| Deferred income taxes | - | 335.39 Million | -780.66 Thousand | - | -334.61 Million | 46.76 Million |
| Stock-based compensation | 1.21 Million | 139.12 Thousand | 572.95 Thousand | 257.18 Thousand | 250.11 Thousand | 1.05 Million |
| Change in working capital | 478.65 Thousand | -381.62 Thousand | 421.15 Thousand | -18.98 Thousand | 458.11 Thousand | 65.33 Thousand |
| Other non-cash items | 1.8 Million | 307.02 Thousand | 783.93 Thousand | 686.00 | 334.61 Million | -46.59 Million |
| Investing Cash Flow | -250.86 Thousand | -4907.00 | -8807.00 | -6770.00 | -230.38 Thousand | -943.1 Thousand |
| Investments in PPE | -250.86 Thousand | -4907.00 | -8807.00 | -6770.00 | -230.38 Thousand | -943.1 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | -237 Thousand | - | - |
| Financing Cash Flow | 1.28 Million | 42.57 Thousand | 177.12 Thousand | -9843.00 | 1.07 Million | 8.91 Million |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | 27.58 Thousand | -9373.00 | -9843.00 | -8372.00 | -12.49 Thousand |
| Common Stock Issuance | 1.32 Million | 49.76 Thousand | 186.5 Thousand | - | 1.08 Million | 8.92 Million |
| Other Financing Activities | -34.77 Thousand | -7190.00 | -9373.00 | -9843.00 | -8372.00 | 8.92 Million |
| Accounts receivables | - | - | - | - | - | 127.96 Thousand |
| Accounts payables | 156.67 Thousand | 20.41 Thousand | -25.89 Thousand | -172.45 Thousand | 334.61 Thousand | -174.72 Thousand |
| Inventory | - | - | - | - | - | 456.64 Thousand |
| Other working capital | 321.98 Thousand | -402.03 Thousand | 447.04 Thousand | 153.46 Thousand | 123.5 Thousand | -344.54 Thousand |
| Cash at beginning of period | 14.53 Million | 7.97 Million | 10.17 Million | 12.98 Million | 14.62 Million | 17.15 Million |
| Cash at end of period | 5.44 Million | 5.44 Million | 7.97 Million | 10.26 Million | 12.98 Million | 14.62 Million |
| Capital Expenditure | -250.86 Thousand | -4907.00 | -8807.00 | -6770.00 | -230.38 Thousand | -943.1 Thousand |
| Effect of forex changes on cash | 2107.00 | -2257.00 | 5605.00 | -1055.00 | -186.00 | -5.95 Million |
| Net cash flow / Change in cash | -9.09 Million | -2.53 Million | -2.2 Million | -2.72 Million | -1.63 Million | -2.53 Million |
| Free Cash Flow | -10.38 Million | -2.57 Million | -2.38 Million | -2.71 Million | -2.71 Million | -11.44 Million |
ALGRO
1710
RMESF
GDYN
VISAGAR
RAJGASES